Publications by authors named "A C Trompeo"

In the last decade, heart transplants using allografts from adult donors after circulatory death, in a controlled setting, controlled donation after circulatory death (cDCD) have been rapidly adopted and widely performed. The selection of retrieval methods has largely been determined by state or institutional guidelines concerning permissible postmortem procedures. A significant majority of cDCD heart recoveries have employed direct procurement and perfusion (DPP) followed by normothermic machine perfusion (NMP) for graft preservation.

View Article and Find Full Text PDF

. Severe tricuspid valve (TV) disease has a strong association with right ventricle dysfunction, heart failure and mortality. Nevertheless, surgical indications for isolated TV disease are still uncommon.

View Article and Find Full Text PDF

An 84-year-old man presented with dyspnea at rest due to severe mitral regurgitation. He first underwent transventricular mitral valve repair with the Harpoon system, which relapsed owing to rupture of neochords. He was definitively treated with transcatheter mitral valve implantation of the Tendyne system 8 months later.

View Article and Find Full Text PDF
Article Synopsis
  • * Among COVID-19 patients, there was a notable prevalence of Gram-positive bacteria-related VAP, but the rates of multidrug-resistant bacteria were similar between both groups.
  • * Patients with COVID-19 exhibited significantly higher ICU and in-hospital mortality rates, with a hazard ratio of 7.95 for 28-day hospital mortality, highlighting the severe impacts of the virus on critically ill patients.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness and safety of continuous percutaneous stellate ganglion block (C-PSGB) compared to thoracic epidural anesthesia (TEA) for treating refractory ventricular arrhythmias in patients with advanced heart disease.
  • C-PSGB was performed on 26 patients, resulting in 59% experiencing complete suppression of arrhythmias and 94% showing overall clinical benefits, while TEA had higher side-effect-related discontinuation rates.
  • Overall, the findings suggest that C-PSGB is a promising and safer alternative for managing these heart conditions, especially for patients on anticoagulation therapy.
View Article and Find Full Text PDF